Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
“Simply put” is an ongoing series. See the introduction for an explanation of the series and the full list of topics that have been or may
Yesterday, I received a letter in the mail that took issue with my piece in CNN last week. One of the points made by the
Tracy Swinburn, manager of the University of Michigan’s Center for Value-Based Insurance Design (V-BID) suggested to me the following resources on the topic: A graphic on
I have been in Bethesda, MD yesterday and today (actually in a meeting room with no windows) serving as a member of the HRSA Negotiated
The history of Medicare vouchers, as told by Dan Diamond, is below. In his piece, Diamond also succinctly summarizes my take on them (not included in
The latest edition is out. As always, it’s chock full of glorious, wonky health policy/politics/research details.
In his budget deficit speech yesterday, Obama said, “We will cut spending on prescription drugs by using Medicare’s purchasing power to drive greater efficiency.” The
I try so hard not to focus on politics that sometimes I convince myself that deep down inside we are more alike than different. While
Yesterday I was quite glum about IPAB’s future, since the March CBO report estimated zero savings over the next decade. Today, President Obama focused on
Austin asks whether the President will borrow VA drug pricing into Medicare. If that’s the plan, it wasn’t mentioned today. What are the details? My
The fact sheet that accompanied Obama’s speech today included the following goal: Give IPAB additional tools to improve the quality of care while reducing costs,
As best I can tell from Obama’s speech and other reporting he has made vague references to the idea of using Medicare’s clout as a